Measurable Residual Disease in ALL: Proof of the Principle Transforming Care for Patients With Hematologic Malignancies

MRD in ALL Program Image
Take advantage of these resources for using MRD as a tool during management of patients with ALL. Watch a CME/CE/ACPE-certified expert panel discussion or one of several patient-focused short videos, read concise expert commentaries, and download the slideset and clinical resource PDF.
Elias Jabbour, MD
Program Director
Joseph D. Khoury, MD
person default
Aaron C. Logan, MD, PhD

On-Demand Video Panel Discussion

This expert panel examines the importance of incorporating MRD testing in ALL and the use of blinatumomab in MRD-positive ALL after CR to provide your patients with better outcomes

Elias Jabbour, MD
Program Director
Joseph D. Khoury, MD person default Aaron C. Logan, MD, PhD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.2 Nursing contact hours Pharmacists: 1.25 contact hours (0.13 CEUs) Released: November 1, 2018 Expiration: October 31, 2019

ClinicalThought

New data emphasize the importance of MRD testing in patients with ALL

Elias Jabbour, MD
Program Director
Released: July 27, 2018

In this commentary, I share my thoughts on the different laboratory techniques available to measure MRD, including flow cytometry, PCR, and NGS-based assays.

Joseph D. Khoury, MD Released: August 29, 2018

Here are my thoughts on the use of blinatumomab to treat patients with B-cell precursor acute lymphoblastic leukemia with measurable residual disease.

person default Aaron C. Logan, MD, PhD Released: September 28, 2018

Downloadable Slideset

In this downloadable slideset from the MRD in ALL video, Elias Jabbour, MD, Joseph D. Khoury, MD, and Aaron C. Logan, MD, PhD, provide expert perspective on incorporating MRD testing in ALL and the use of blinatumomab in MRD-positive ALL after CR to provide your patients with better outcomes.

Elias Jabbour, MD
Program Director
Joseph D. Khoury, MD person default Aaron C. Logan, MD, PhD
Released: November 1, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

In partnership with
Grace Logo
This activity is supported by educational grants from
Adaptive Biotechnologies
Amgen

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?